Literature DB >> 571250

Serum cholinesterase levels in patients with cancer.

P Kaniaris, A Fassoulaki, K Liarmakopoulou, E Dermitzakis.   

Abstract

Serum cholinesterase levels were determined in 180 patients with carcinoma and in 146 normal subjects. Serum cholinesterase activity was significantly lower in patients suffering from cancer than in normal controls, though still within the normal range. The degree of depression of serum cholinesterase activity was influenced by the extent to which the malignancy had spread and by the site of the primary lesion.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 571250

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

1.  Protective effects of Moringa oleifera Lam. leaves against arsenic-induced toxicity in mice.

Authors:  Afzal Sheikh; Fouzia Yeasmin; Smita Agarwal; Mashiur Rahman; Khairul Islam; Ekhtear Hossain; Shakhawoat Hossain; Md Rezaul Karim; Farjana Nikkon; Zahangir Alam Saud; Khaled Hossain
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

2.  Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).

Authors:  Qingnan Zhao; Xiajing Gu; Chun Zhang; Qin Lu; Hongzhuan Chen; Lu Xu
Journal:  Cancer Biol Ther       Date:  2015-03-16       Impact factor: 4.742

3.  Association between arsenic exposure and plasma cholinesterase activity: a population based study in Bangladesh.

Authors:  Nurshad Ali; Md Ashraful Hoque; Abedul Haque; Kazi Abdus Salam; Md Rezaul Karim; Aminur Rahman; Khairul Islam; Zahangir Alam Saud; Md Abdul Khalek; Anwarul Azim Akhand; Mostaque Hossain; Abul Mandal; Md Rezaul Karim; Hideki Miyataka; Seiichiro Himeno; Khaled Hossain
Journal:  Environ Health       Date:  2010-07-10       Impact factor: 5.984

4.  Reduced butyrylcholinesterase activity is an early indicator of trauma-induced acute systemic inflammatory response.

Authors:  Aleksandar R Zivkovic; Jochen Bender; Thorsten Brenner; Stefan Hofer; Karsten Schmidt
Journal:  J Inflamm Res       Date:  2016-11-18

5.  Integrative analysis for the discovery of lung cancer serological markers and validation by MRM-MS.

Authors:  Jihye Shin; Sang-Yun Song; Hee-Sung Ahn; Byung Chull An; Yoo-Duk Choi; Eun Gyeong Yang; Kook-Joo Na; Seung-Taek Lee; Jae-Il Park; Seon-Young Kim; Cheolju Lee; Seung-Won Lee
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

6.  Cholinesterase-like organocatalysis by imidazole and imidazole-bearing molecules.

Authors:  Paola Nieri; Sara Carpi; Stefano Fogli; Beatrice Polini; Maria Cristina Breschi; Adriano Podestà
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.